Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Cancer, Cannabis, and the Search for Relief.

Chwistek M.

J Natl Compr Canc Netw. 2019 Sep 1;17(9):1142-1144. doi: 10.6004/jnccn.2019.7347. No abstract available.

PMID:
31487679
2.

Cannabis-based medicines for chronic neuropathic pain in adults.

Mücke M, Phillips T, Radbruch L, Petzke F, Häuser W.

Cochrane Database Syst Rev. 2018 Mar 7;3:CD012182. doi: 10.1002/14651858.CD012182.pub2. Review.

3.

Cannabis use for chronic non-cancer pain: results of a prospective survey.

Ware MA, Doyle CR, Woods R, Lynch ME, Clark AJ.

Pain. 2003 Mar;102(1-2):211-6.

PMID:
12620613
4.

Patient-Reported Symptom Relief Following Medical Cannabis Consumption.

Stith SS, Vigil JM, Brockelman F, Keeling K, Hall B.

Front Pharmacol. 2018 Aug 28;9:916. doi: 10.3389/fphar.2018.00916. eCollection 2018.

5.

Experience of adjunctive cannabis use for chronic non-cancer pain: findings from the Pain and Opioids IN Treatment (POINT) study.

Degenhardt L, Lintzeris N, Campbell G, Bruno R, Cohen M, Farrell M, Hall WD.

Drug Alcohol Depend. 2015 Feb 1;147:144-50. doi: 10.1016/j.drugalcdep.2014.11.031. Epub 2014 Dec 10.

PMID:
25533893
6.

Reasons for cannabis use and effects of cannabis use as reported by patients with psychotic disorders.

Dekker N, Linszen DH, De Haan L.

Psychopathology. 2009;42(6):350-60. doi: 10.1159/000236906. Epub 2009 Sep 15. Review.

PMID:
19752588
7.

Restored Self: A Phenomenological Study of Pain Relief by Cannabis.

Lavie-Ajayi M, Shvartzman P.

Pain Med. 2018 Sep 12. doi: 10.1093/pm/pny176. [Epub ahead of print]

PMID:
30215782
8.

Pain Relief as a Motivation for Cannabis Use Among Young Adult Users With and Without Chronic Pain.

Fales JL, Ladd BO, Magnan RE.

J Pain. 2019 Aug;20(8):908-916. doi: 10.1016/j.jpain.2019.02.001. Epub 2019 Feb 6.

PMID:
30735731
9.

False News of a Cannabis Cancer Cure.

Shi S, Brant AR, Sabolch A, Pollom E.

Cureus. 2019 Jan 19;11(1):e3918. doi: 10.7759/cureus.3918.

10.
11.

Are cannabis prevalence estimates comparable across countries and regions? A cross-cultural validation using search engine query data.

Steppan M, Kraus L, Piontek D, Siciliano V.

Int J Drug Policy. 2013 Jan;24(1):23-9. doi: 10.1016/j.drugpo.2012.05.002. Epub 2012 Jul 17.

PMID:
22809479
12.

Prospectively surveying health-related quality of life and symptom relief in a lot-based sample of medical cannabis-using patients in urban Washington State reveals managed chronic illness and debility.

Aggarwal SK, Carter GT, Sullivan MD, Zumbrunnen C, Morrill R, Mayer JD.

Am J Hosp Palliat Care. 2013 Sep;30(6):523-31. doi: 10.1177/1049909112454215. Epub 2012 Aug 10.

PMID:
22887696
13.

Cannabis-related cognitive impairment: a prospective evaluation of possible influences on patients with cancer during chemotherapy treatment as a pilot study.

Bar-Sela G, Tauber D, Mitnik I, Sheinman-Yuffe H, Bishara-Frolova T, Aharon-Peretz J.

Anticancer Drugs. 2019 Jan;30(1):91-97. doi: 10.1097/CAD.0000000000000685.

PMID:
30540595
14.

The Association between Cannabis Product Characteristics and Symptom Relief.

Stith SS, Vigil JM, Brockelman F, Keeling K, Hall B.

Sci Rep. 2019 Feb 25;9(1):2712. doi: 10.1038/s41598-019-39462-1.

15.

Adverse Reactions Associated With Cannabis Consumption as Evident From Search Engine Queries.

Yom-Tov E, Lev-Ran S.

JMIR Public Health Surveill. 2017 Oct 26;3(4):e77. doi: 10.2196/publichealth.8391.

16.

Survey of Australians using cannabis for medical purposes.

Swift W, Gates P, Dillon P.

Harm Reduct J. 2005 Oct 4;2:18.

17.

Therapeutic aspects of cannabis and cannabinoids.

Robson P.

Br J Psychiatry. 2001 Feb;178:107-15. Review.

PMID:
11157423
18.

Cannabinoid Hyperemesis Syndrome: Diagnosis, Pathophysiology, and Treatment-a Systematic Review.

Sorensen CJ, DeSanto K, Borgelt L, Phillips KT, Monte AA.

J Med Toxicol. 2017 Mar;13(1):71-87. doi: 10.1007/s13181-016-0595-z. Epub 2016 Dec 20. Review.

19.

[Efficacy, tolerability, and safety of cannabinoids in gastroenterology: A systematic review].

Volz MS, Siegmund B, Häuser W.

Schmerz. 2016 Feb;30(1):37-46. doi: 10.1007/s00482-015-0087-0. Review. German.

PMID:
26809974
20.

Neuromodulators for pain management in rheumatoid arthritis.

Richards BL, Whittle SL, Buchbinder R.

Cochrane Database Syst Rev. 2012 Jan 18;1:CD008921. doi: 10.1002/14651858.CD008921.pub2. Review.

PMID:
22258992

Supplemental Content

Support Center